Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

United States News News

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding
United States Latest News,United States Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding PLOSONE flavor fragrance compounds chemicals COVID19 coronavirus covid ACE2

By Dr. Sanchari Sinha Dutta, Ph.D.Dec 20 2022Reviewed by Danielle Ellis, B.Sc. A study published in the journal PLOS ONE describes the antiviral activity of flavor/fragrance compositions against severe acute respiratory syndrome coronavirus 2 . Flavor/fragrance compositions exhibit an antiviral effect by blocking viral entry into host cells.

Flavors and fragrances are organic compounds with distinctive tastes and pleasant odors. Many flavor/fragrance compositions are widely used because of many beneficial effects, including relaxing and refreshing effects. These compositions are safe and inexpensive and are mainly used as food additives, perfumes, and ingredients of daily commodities.

SARS-CoV-2 variants with spike RBD mutations that emerged during the pandemic have shown significantly higher viral fitness than the original strain with wildtype RBD. Considering this, scientists selected 8 representative flavor/fragrance compositions and tested their ability to inhibit the interactions between different RBD mutants and ACE2.

Among selected 8 representative flavor/fragrance compositions, 4 were less cytotoxic, and the other 4 were cytotoxic.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2 biorxivpreprint PittHealthSci antibody antibodies vaccine vaccination SARSCoV2 COVID19 covid coronavirus
Read more »

What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?Researchers assessed the impact of ceramide (CER) and cholesterol (CHOL) on membrane fusion mediated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Read more »

SARS-CoV-2 structural proteins trigger periodontal fibrosisSARS-CoV-2 structural proteins trigger periodontal fibrosisResearchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.
Read more »

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infectionMilk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infectionMilk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection medrxivpreprint UCSF SARSCoV2 COVID19 Booster Vaccine Vaccination
Read more »

Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German statesSeroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German statesResearchers measured the seroprevalence against SARS-CoV-2 in blood donors from the states of Hesse, Lower Saxony, and North Rhine-Westphalia in Germany to determine the incidence of undetected asymptomatic SARS-CoV-2 infections.
Read more »

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker populationRise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker populationRise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population researchsquare USC UCIrvine antibody SARSCoV2 healthcare mRNA vaccine vaccination COVID19 coronavirus covid
Read more »



Render Time: 2025-03-04 14:37:30